Product Information
ALMOTRIPTAN MALATE 12.5 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $16.8566 per EA under NDC 00378524685. Its NADAC has been published 563 times since Dec 23, 2015.
FDA first approved this application on Nov 9, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378524685
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALMOTRIPTAN MALATEApproval Type
Generic (ANDA)
FDA Application
ANDA205171FDA Approved
11/9/2015
TE Code
AB
On Market Since
11/10/2015
Pharmacological Classes
Price Statistics
The NADAC for ALMOTRIPTAN MALATE 12.5 MG TAB has been published 563 times since Dec 23, 2015, and over the history we have for it it has declined 46.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.8566 per EA |
|---|---|
| All-time high | $31.3479 (Jan 13, 2016) |
| All-time low | $13.4937 (May 22, 2024) |
| 52-week high | $18.5589 |
| 52-week low | $16.8566 |
| Median price | $21.7368 |
| Average price | $21.9897 |
| Largest weekly change | +34.3% (Jun 19, 2024) |
| Weeks tracked | 563 |
| Tracking since | Dec 23, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Almotriptan market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Almotriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALMOTRIPTAN MALATE 12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALMOTRIPTAN MALATE 12.5 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $16.8566 per EA (NDC 00378524685), effective Sep 30, 2026.
How has the price of ALMOTRIPTAN MALATE 12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for ALMOTRIPTAN MALATE 12.5 MG TAB has declined 46.2%. It has been tracked across 563 weekly CMS publications since Dec 23, 2015.
What are the highest and lowest recorded NADAC prices for ALMOTRIPTAN MALATE 12.5 MG TAB?
Since Dec 23, 2015, the NADAC for ALMOTRIPTAN MALATE 12.5 MG TAB has ranged from a low of $13.4937 (May 22, 2024) to a high of $31.3479 (Jan 13, 2016), with a median of $21.7368 per EA.
Are there cheaper alternatives to ALMOTRIPTAN MALATE 12.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of ALMOTRIPTAN MALATE 12.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALMOTRIPTAN MALATE 12.5 MG TAB?
ALMOTRIPTAN MALATE 12.5 MG TAB (NDC 00378524685) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.